Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Eye Care

Journal Scan / Research · April 30, 2022

Arm-to-Retina Time Predicts Visual Outcome of Anti-VEGF Treatment for CRVO-Related Macular Edema

Scientific Reports


Additional Info

Scientific Reports
Arm-to-retina time predicts visual outcome of anti-vascular endothelial growth factor treatment for macular edema due to central retinal vein occlusion
Sci Rep 2022 Feb 09;12(1)2194, T Takei, N Nagai, K Ohkoshi, Y Ozawa

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading